BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 29102366)

  • 1. Time course of secondary mitral regurgitation in patients with heart failure receiving cardiac resynchronization therapy: Impact on long-term outcome beyond left ventricular reverse remodelling.
    Binda C; Menet A; Appert L; Ennezat PV; Delelis F; Castel AL; Le Goffic C; Guyomar Y; Ringlé A; Guerbaai RA; Graux P; Tribouilloy C; Maréchaux S
    Arch Cardiovasc Dis; 2018 May; 111(5):320-331. PubMed ID: 29102366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of surgical treatment of secondary severe mitral regurgitation in patients with end-stage heart failure: Advantage of prosthesis insertion.
    Théron A; Morera P; Resseguier N; Grisoli D; Norscini G; Riberi A; Collart F; Habib G; Avierinos JF
    Arch Cardiovasc Dis; 2019 Feb; 112(2):95-103. PubMed ID: 30600216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy.
    van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ
    Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
    Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW
    Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony.
    Carluccio E; Biagioli P; Alunni G; Murrone A; Pantano P; Biscottini E; Zuchi C; Zingarini G; Cavallini C; Ambrosio G
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1067-76. PubMed ID: 21999865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
    Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L
    Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cardiac resynchronization therapy on left ventricular and mitral valve geometry and secondary mitral regurgitation in patients with left bundle branch block.
    Mihos CG; Santana O; Yucel E; Capoulade R; Upadhyay GA; Orencole MP; Singh JP; Picard MH
    Echocardiography; 2019 Aug; 36(8):1450-1458. PubMed ID: 31424113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling.
    Martens P; Verbrugge FH; Bertrand PB; Verhaert D; Vandervoort P; Dupont M; Tang WHW; Janssens S; Mullens W
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007813. PubMed ID: 30354673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation.
    Mihos CG; Yucel E; Capoulade R; Orencole MP; Upadhyay GA; Santana O; Singh JP; Picard MH
    Echocardiography; 2017 Nov; 34(11):1561-1567. PubMed ID: 28895197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy.
    Liang YJ; Zhang Q; Fung JW; Chan JY; Yip GW; Lam YY; Yu CM
    Eur Heart J; 2010 Oct; 31(19):2359-68. PubMed ID: 20501482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of left ventricular reverse remodeling and performance improvement after cardiac resynchronization therapy: A prospective study.
    Menet A; Guyomar Y; Ennezat PV; Graux P; Castel AL; Delelis F; Heuls S; Cuvelier E; Gevaert C; Le Goffic C; Tribouilloy C; Maréchaux S
    Int J Cardiol; 2016 Feb; 204():6-11. PubMed ID: 26649446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry.
    Mihos CG; Yucel E; Capoulade R; Orencole MP; Upadhyay GA; Santana O; Singh JP; Picard MH
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):114-121. PubMed ID: 29222864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy.
    Verbrugge FH; Verhaert D; Grieten L; Dupont M; Rivero-Ayerza M; De Vusser P; Van Herendael H; Reyskens R; Vandervoort P; Tang WH; Mullens W
    Europace; 2013 Dec; 15(12):1747-56. PubMed ID: 23821473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.